Intercept Pharmaceuticals Aktie

Kaufen
Verkaufen
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Bei einem anderen Broker handeln Smartphone
Div. Rendite 0,00%

WKN A1J5U0

ISIN US45845P1084

Symbol ICPT


Intercept Pharmaceuticals Aktie Analyse

10.05.19 Intercept Pharmaceuticals Buy B. Riley FBR
14.01.19 Intercept Pharmaceuticals Buy Laidlaw
12.12.18 Intercept Pharmaceuticals Buy B. Riley FBR
19.11.18 Intercept Pharmaceuticals Outperform Oppenheimer & Co. Inc.
01.10.18 Intercept Pharmaceuticals Overweight Cantor Fitzgerald
03.08.18 Intercept Pharmaceuticals Hold Laidlaw
01.11.17 Intercept Pharmaceuticals Buy Laidlaw
01.11.17 Intercept Pharmaceuticals Neutral Cantor Fitzgerald
04.10.17 Intercept Pharmaceuticals Outperform RBC Capital Markets
26.09.17 Intercept Pharmaceuticals Outperform RBC Capital Markets
22.09.17 Intercept Pharmaceuticals Hold Laidlaw
15.09.17 Intercept Pharmaceuticals Outperform RBC Capital Markets
04.08.17 Intercept Pharmaceuticals Outperform BMO Capital Markets
05.05.17 Intercept Pharmaceuticals Hold Laidlaw
20.01.17 Intercept Pharmaceuticals Hold Needham & Company, LLC
30.12.16 Intercept Pharmaceuticals Outperform Wedbush Morgan Securities Inc.
06.07.16 Intercept Pharmaceuticals Sell Cantor Fitzgerald
01.06.16 Intercept Pharmaceuticals Outperform Wedbush Morgan Securities Inc.
08.04.16 Intercept Pharmaceuticals Outperform BMO Capital Markets
24.02.16 Intercept Pharmaceuticals Outperform Wedbush Morgan Securities Inc.
18.11.15 Intercept Pharmaceuticals Outperform Oppenheimer & Co. Inc.
11.11.15 Intercept Pharmaceuticals Mkt Perform FBR Capital
21.05.15 Intercept Pharmaceuticals overweight Barclays Capital
17.04.15 Intercept Pharmaceuticals Buy UBS AG
17.03.15 Intercept Pharmaceuticals Hold MLV Capital
28.01.15 Intercept Pharmaceuticals Outperform Oppenheimer & Co. Inc.
04.12.14 Intercept Pharmaceuticals Outperform Robert W. Baird & Co. Incorporated
03.12.14 Intercept Pharmaceuticals Underperform FBR Capital
10.11.14 Intercept Pharmaceuticals Underperform FBR Capital
Werbung